American Well Co. (NYSE:AMWL – Get Rating) CEO Roy Schoenberg sold 125,508 shares of the business's stock in a transaction that occurred on Wednesday, September 21st. The shares were sold at an average price of $3.74, for a total value of $469,399.92. Following the completion of the transaction, the chief executive officer now owns 2,425,957 shares of the company's stock, valued at $9,073,079.18. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

American Well Stock Down 4.8 %

Shares of American Well stock opened at $3.54 on Friday. American Well Co. has a 12-month low of $2.52 and a 12-month high of $10.27. The stock has a market cap of $968.44 million, a P/E ratio of -3.98 and a beta of -0.06. The business's 50 day moving average is $4.42 and its 200-day moving average is $4.04.

American Well (NYSE:AMWL – Get Rating) last posted its quarterly earnings results on Thursday, August 4th. The company reported ($0.25) earnings per share for the quarter, meeting analysts' consensus estimates of ($0.25). American Well had a negative return on equity of 19.36% and a negative net margin of 90.47%. The business had revenue of $64.52 million for the quarter, compared to analysts' expectations of $64.13 million. During the same quarter in the prior year, the business earned ($0.15) EPS. The firm's revenue for the quarter was up 7.1% on a year-over-year basis. On average, sell-side analysts expect that American Well Co. will post -1.02 EPS for the current year.

Institutional Investors Weigh In On American Well

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on AMWL shares. Truist Financial started coverage on American Well in a research report on Wednesday, September 7th. They set a "hold" rating and a $5.00 price target for the company. Piper Sandler reduced their price target on American Well from $6.00 to $5.00 in a research report on Wednesday, September 7th. Five investment analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat.com, American Well has a consensus rating of "Hold" and a consensus target price of $7.78.

American Well Company Profile

(Get Rating)

American Well Corporation operates as a telehealth software company that enables digital delivery of care for healthcare. The company products offer urgent care; scheduled visits; acute behavioral health; telestroke; pediatrics; retail health, school health, and home settings. Its application offers urgent care; pediatrics; therapy; menopause nutrition; end-stage renal disease and dialysis; dermatology care; behavioral health therapy; and musculoskeletal care.

Featured Stories

• Get a free copy of the StockNews.com research report on American Well (AMWL)
• Will Wall Street's Enthusiasm About Datadog Lead To Big Gains?
• MarketBeat: Week in Review 9/19 – 9/23
• Why Does Tesla Stock Remain Resilient?
• Is Costco's Post-Earnings Price Weakness A Good Time To Buy?
• 2 Semiconductor Stocks To Watch For Reversals

Receive News & Ratings for American Well Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Well and related companies with MarketBeat.com's FREE daily email newsletter.